Gagandeep Kang, vice-chair of Coalition for Epidemic Preparedness Innovations (CEPI), said that several multinational companies are talking to Indian manufacturers to see if their vaccines can be made in the country, The Economic Times reported on Sunday.
"We have a long way to go. But we are on the right track, and we are moving as fast as possible — faster than what we thought was possible six months ago," Kang said.
Cipla CEO Umang Vohra noted that "we need private-public partnerships and the communities to take this forward, as we saw with polio in India."
"India is one of the few developing countries with production capacity, and this is important. Most governments and countries should be vocal about being local in manufacturing vaccines and also regional cooperation," he added.
To read more NewsPoints articles, click here.